R
Regeneron
Resolving
Resolving brand mentions across new media
Regeneron
8
Mentions
369.4K
Views
“Pharmaceutical company that initially won the auction for 23andMe's assets before Anne Wojcicki's successful counter-bid.”
“Biotech company whose shares fell after a failed phase three drug trial.”
“Biotech firm whose melanoma study failed.”
“Biotechnology company that developed the gene therapy and is providing it for free.”
“Biotech company cited as a historical success story in innovation.”
Arcmira media summary
Arcmira tracks where Regeneron is discussed across indexed YouTube videos, transcripts, channels, and related entities.
Pharmaceutical company that initially won the auction for 23andMe's assets before Anne Wojcicki's successful counter-bid.
Biotech company whose shares fell after a failed phase three drug trial.
Biotech firm whose melanoma study failed.
Biotechnology company that developed the gene therapy and is providing it for free.
Biotech company cited as a historical success story in innovation.
Arcmira tracks 8 indexed media appearances or mentions for Regeneron, tied to source videos, channels, and transcript-derived context.
Arcmira uses indexed YouTube videos and transcripts. Representative source evidence on this page includes "The Rise, Bankruptcy and Rebirth of 23andMe | The Circuit" with transcript-derived context and links when available.
Regeneron is connected to Women's Health, Whole Genome Sequencing, Rare Earths Race in Arcmira's media graph.